Showing results (1491-1500 of 1,573) with videos related to
Sort By:
Pageof 158
Biorxiv : the Preprint Server for Biology|March 27, 2026
Comparison of Four Assays That Measure Antibodies to Ebola Virus GlycoproteinIrina Maljkovic Berry, Safaa Ben Farhat, Viviane Callier, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 24, 2025
International survey on training of dermatology residents in supportive oncodermatology: the RESCUE studyAriadna Ortiz-Brugués, Davide Fattore, Marie Boileau, et al.Annals of Neurology|February 5, 1998
Magnetic resonance studies of intramuscular interferon beta-1a for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research GroupJ H Simon, L D Jacobs, M Campion, et al.Neurology|August 1, 1997
Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)R A Rudick, D E Goodkin, L D Jacobs, et al.Annals of Neurology|March 1, 1996
Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)L D Jacobs, D L Cookfair, R A Rudick, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|February 13, 1999
Comparing the ability of various compositive outcomes to discriminate treatment effects in MS clinical trials. The Multiple Sclerosis Collaborative Research Group (MSCRG)D E Goodkin, R L Priore, K E Wende, et al.Journal of Neuroimmunology|June 23, 1999
Cerebrospinal fluid abnormalities in a phase III trial of Avonex (IFNbeta-1a) for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research GroupR A Rudick, D L Cookfair, N A Simonian, et al.Cellular & Molecular Immunology|January 4, 2023
CXCR5+PD-1++ CD4+ T cells colonize infant intestines early in life and promote B cell maturationAna Jordan-Paiz, Glòria Martrus, Fenja L Steinert, et al.The New England Journal of Medicine|December 14, 2022
Randomized Trial of Vaccines for Zaire Ebola Virus Disease, Mark Kieh, Laura Richert, et al.The Lancet. Infectious Diseases|February 8, 2020
PRIMVAC vaccine adjuvanted with Alhydrogel or GLA-SE to prevent placental malaria: a first-in-human, randomised, double-blind, placebo-controlled studySodiomon B Sirima, Laura Richert, Arnaud Chêne, et al.Pageof 158